Start the year with your health as a major priority, get your cervical cancer screening done this year. The National Cervical Cancer Coalition also requests the women to make this their New Year's resolution and talk to their health care providers about it.
January is Cervical Health Awareness Month, and the National Cervical Cancer Coalition is urging women to make a New Year's resolution to talk with their health care providers.
‘Unacceptable Low’ Cervical Cancer Screening Rates, Finds Mayo Research
According to a Mayo research, percentage of women undergoing cervical cancer screening are below the levels reported in the national data.
Advertisement
‘Cervical cancer if found early is highly treatable, so let’s get yourself screened this year’
Tweet it Now
Roughly 12,000 women in the U.S. are diagnosed with cervical cancer each year. About 4,000 die from it, even though there's a vaccine to prevent it.
"When cervical cancer is found early, it is highly treatable," said Dr. Sarah Ramirez, a family medicine physician with Penn State Health. "So it's important to make sure you are being screened for this disease."
![Research Provides Scope for New Cervical Cancer Treatments]( "Research Provides Scope for New Cervical Cancer Treatments")
Researchers at the University of Virginia School of Medicine have made a recent discovery that provides scope for new treatments for cervical cancer and other types of cancer caused by the human papillomavirus (HPV)
While many women are still suffering and dying from it, cervical cancer incidence is on a downward trajectory. It's no longer leading cancer caused by human papillomavirus (HPV). That's because in 2006, Gardasil — a vaccine that prevents certain cancers and diseases caused by the nine HPV types — was introduced, Ramirez said.
"As we continue to use this vaccine, our mindset should shift from seeing Gardasil as a vaccine that prevents a sexually transmitted disease related to cancer. Instead, we should see it as a cancer prevention tool," she said.
In October, the U.S. Food and Drug Administration approved the application of Gardasil to include both women and men younger than 45 years old - whereas it used to be approved only for individuals up to the age of 26.
"This approval speaks to the power of the vaccine to prevent cancer," Ramirez said.
But testing and early detection remain an important key to prevention, and many are still at risk.
"While we have made significant strides to decrease mortality from cervical cancer, we continue to see our minority females most commonly stricken with the disease," Ramirez said. "As the U.S. population becomes increasingly diverse, it behooves us to examine why there is a disparity in cervical cancer health with our vulnerable populations and why they're not getting screened regularly."
Hispanic or Latina women get fewer Pap tests than non-Hispanic white and black women, even though Hispanics have the highest incidence of cervical cancer, according to the American Cancer Society Cancer Action Network. Similarly, African American females have the highest rate of death due to cervical cancer, according to Centers for Disease Control and Prevention.
Waiting for the disease to show itself can be risky. Symptoms of cervical cancer may not show up until the cancer is advanced. It develops slowly, starting as a precancerous condition known as dysplasia that, if left untreated, may lead to cancer.
Symptoms include abnormal vaginal bleeding, unusual discharge, periods that last longer or have a heavier flow than usual, and bleeding after menopause.
HPV is the main cause of cervical cancer, and all women are at risk for it. The disease occurs most often in women over the age of 30, according to the CDC.
According to the United States Preventive Services Task Force, all women between 21 and 65 years of age should have cervical cancer screening with cytology (Pap smear) every three years. Women between the ages of 30 and 65 may opt instead to lengthen the interval between screening with a combination of cytology and HPV testing every five years.
HPV is a common virus, with 79 million Americans currently infected and about 14 million people becoming newly infected yearly, according to the CDC. HPV is passed from one person to another during sex, and at least half of sexually active people will have HPV at some point in their lives, even though relatively few women will develop cervical cancer.
Other risk factors of cervical cancer include smoking, autoimmune diseases, using birth control pills for five or more years, giving birth to three or more children and having several sexual partners.
Source: Newswise
Research Provides Scope for New Cervical Cancer Treatments
Researchers at the University of Virginia School of Medicine have made a recent discovery that provides scope for new treatments for cervical cancer and other types of cancer caused by the human papillomavirus (HPV)
Advertisement
While many women are still suffering and dying from it, cervical cancer incidence is on a downward trajectory. It's no longer leading cancer caused by human papillomavirus (HPV). That's because in 2006, Gardasil — a vaccine that prevents certain cancers and diseases caused by the nine HPV types — was introduced, Ramirez said.
"As we continue to use this vaccine, our mindset should shift from seeing Gardasil as a vaccine that prevents a sexually transmitted disease related to cancer. Instead, we should see it as a cancer prevention tool," she said.
In October, the U.S. Food and Drug Administration approved the application of Gardasil to include both women and men younger than 45 years old - whereas it used to be approved only for individuals up to the age of 26.
"This approval speaks to the power of the vaccine to prevent cancer," Ramirez said.
But testing and early detection remain an important key to prevention, and many are still at risk.
"While we have made significant strides to decrease mortality from cervical cancer, we continue to see our minority females most commonly stricken with the disease," Ramirez said. "As the U.S. population becomes increasingly diverse, it behooves us to examine why there is a disparity in cervical cancer health with our vulnerable populations and why they're not getting screened regularly."
Hispanic or Latina women get fewer Pap tests than non-Hispanic white and black women, even though Hispanics have the highest incidence of cervical cancer, according to the American Cancer Society Cancer Action Network. Similarly, African American females have the highest rate of death due to cervical cancer, according to Centers for Disease Control and Prevention.
Waiting for the disease to show itself can be risky. Symptoms of cervical cancer may not show up until the cancer is advanced. It develops slowly, starting as a precancerous condition known as dysplasia that, if left untreated, may lead to cancer.
Symptoms include abnormal vaginal bleeding, unusual discharge, periods that last longer or have a heavier flow than usual, and bleeding after menopause.
HPV is the main cause of cervical cancer, and all women are at risk for it. The disease occurs most often in women over the age of 30, according to the CDC.
According to the United States Preventive Services Task Force, all women between 21 and 65 years of age should have cervical cancer screening with cytology (Pap smear) every three years. Women between the ages of 30 and 65 may opt instead to lengthen the interval between screening with a combination of cytology and HPV testing every five years.
HPV is a common virus, with 79 million Americans currently infected and about 14 million people becoming newly infected yearly, according to the CDC. HPV is passed from one person to another during sex, and at least half of sexually active people will have HPV at some point in their lives, even though relatively few women will develop cervical cancer.
Other risk factors of cervical cancer include smoking, autoimmune diseases, using birth control pills for five or more years, giving birth to three or more children and having several sexual partners.
Source: Newswise
New Epigenetic Cervical Cancer Test Shows 100 Percent Detection Rate
New screening method for cervical cancer has shown 100 percent accuracy in testing compared to human papillomavirus (HPV) and Pap smear test at a reduced cost.
Advertisement
 India should Prioritize Cervical Cancer ScreeningIndia could reduce cervical cancer deaths by prioritizing screening and prevention, reveals a global expert. | Advertisement
|
Advertisement
Recommended Reading
Latest General Health News
In India, youth must be aware of the diseases linked to cigarette smoking and tobacco consumption, causing a form of healthcare emergency.
Direct coastal access may represent a viable route to public health promotion, but the relationships of coastal living are not strongest among lower-income groups.
New research by Tinnitus UK has found that over four million gardeners are putting their hearing capacity at risk this summer without using safety protection.
Mucus plugs could be targeted to help reduce fatalities from chronic obstructive pulmonary disease.
The development of reliable curative therapies for multiple sclerosis could significantly reduce the economic burden of the disease on patients and wider society.